Thanks In To Win.
Apart from issues with remittance for Denedron that the market became aware of in early August, the other elephant in the room at that time was obviously the expected benefits & sales from Provenge.
Now that may explain why Denedron SP tanked, but why did our Prima get all belted up as well?
Anyway, hard to acurately answer that one, suffice to say that it would be nice if the FDA got of thier collective fat bums & approve CVac sooner rather than later.
could prima become dendreon's big brother ?, page-3
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.005(1.69%) |
Mkt cap ! $436.3M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 31.0¢ | 29.0¢ | $504.5K | 1.673M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39998 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 3997 | 1 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |